Patents by Inventor Ryosuke MISU

Ryosuke MISU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted cyclopenta[c]pyrroles as ABHD6 antagonists
    Patent number: 12600730
    Abstract: A drug is provided, which contains, as an active ingredient, a compound having ABHD6 inhibitory activity in prevention and/or treatment of a disease associated with ABHD6. A compound of formula (I-A) or a pharmaceutically acceptable salt thereof has ABHD6 inhibitory activity and therefore is useful as a pharmaceutical ingredient having potent ABHD6 inhibitory activity in the prevention and/or treatment of a disease associated with ABHD6: in which all symbols represent the same meaning as the symbols described in the specification.
    Type: Grant
    Filed: April 8, 2024
    Date of Patent: April 14, 2026
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Atsushi Yoshida, Ryuichi Hyakutake, Nozomu Nagashima, Ryosuke Misu, Shohei Mori
  • ABHD6 ANTAGONIST
    Publication number: 20260083735
    Abstract: A drug is provided, which contains, as an active ingredient, a compound having ABHD6 inhibitory activity in prevention and/or treatment of a disease associated with ABHD6. A compound represented by general formula (I) or a pharmaceutically acceptable salt thereof has ABHD6 inhibitory activity and therefore is useful as a pharmaceutical ingredient having potent ABHD6 inhibitory activity in the prevention and/or treatment of a disease associated with ABHD6: in which all symbols represent the same meaning as the symbols described in the specification.
    Type: Application
    Filed: September 29, 2023
    Publication date: March 26, 2026
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Atsushi YOSHIDA, Ryuichi HYAKUTAKE, Nozomu NAGASHIMA, Ryosuke MISU, Shohei MORI
  • SUBSTITUTED CYCLOPENTA[c]PYRROLES AS ABHD6 ANTAGONISTS
    Publication number: 20240270755
    Abstract: A drug is provided, which contains, as an active ingredient, a compound having ABHD6 inhibitory activity in prevention and/or treatment of a disease associated with ABHD6. A compound of formula (I-A) or a pharmaceutically acceptable salt thereof has ABHD6 inhibitory activity and therefore is useful as a pharmaceutical ingredient having potent ABHD6 inhibitory activity in the prevention and/or treatment of a disease associated with ABHD6: in which all symbols represent the same meaning as the symbols described in the specification.
    Type: Application
    Filed: April 8, 2024
    Publication date: August 15, 2024
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Atsushi Yoshida, Ryuichi Hyakutake, Nozomu Nagashima, Ryosuke Misu, Shohei Mori
  • Substituted cyclopenta[c]pyrroles as ABHD6 antagonists
    Patent number: 11981682
    Abstract: A drug is provided, which containing, as an active ingredient, a compound having ABHD6 inhibitory activity in prevention and/or treatment of a disease associated with ABHD6. A compound of formula (I-A) or a pharmaceutically acceptable salt thereof has ABHD6 inhibitory activity and therefore is useful as a pharmaceutical ingredient having potent ABHD6 inhibitory activity in the prevention and/or treatment of a disease associated with ABHD6: in which all symbols represent the same meaning as the symbols described in the specification.
    Type: Grant
    Filed: September 22, 2023
    Date of Patent: May 14, 2024
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Atsushi Yoshida, Ryuichi Hyakutake, Nozomu Nagashima, Ryosuke Misu, Shohei Mori
  • ABHD6 ANTAGONIST
    Publication number: 20240010658
    Abstract: A drug is provided, which containing, as an active ingredient, a compound having ABHD6 inhibitory activity in prevention and/or treatment of a disease associated with ABHD6. A compound of formula (I-A) or a pharmaceutically acceptable salt thereof has ABHD6 inhibitory activity and therefore is useful as a pharmaceutical ingredient having potent ABHD6 inhibitory activity in the prevention and/or treatment of a disease associated with ABHD6: in which all symbols represent the same meaning as the symbols described in the specification.
    Type: Application
    Filed: September 22, 2023
    Publication date: January 11, 2024
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Atsushi YOSHIDA, Ryuichi HYAKUTAKE, Nozomu NAGASHIMA, Ryosuke MISU, Shohei MORI